Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis

Journal of Cardiology

Volumn 62, Issue 5, 2013, Pages 320-325

  Yodogawa, Kenji ^a   Seino, Yoshihiko ^b   Shiomura, Reiko ^a   Takahashi, Kenta ^a   Tsuboi, Ippei ^a   Uetake, Shunsuke ^a   Hayashi, Hiroshi ^a   Horie, Tsutomu ^a   Iwasaki, Yu ki ^a   Hayashi, Meiso ^a   Miyauchi, Yasushi ^a   Shimizu, Wataru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

Author keywords

Atrioventricular block; Cardiac sarcoidosis; Corticosteroid

Indexed keywords

PREDNISONE;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CLINICAL ARTICLE; CONVALESCENCE; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAINTENANCE DRUG DOSE; MALE; PREVALENCE; RETROSPECTIVE STUDY; SARCOIDOSIS;

ATRIOVENTRICULAR BLOCK; CARDIAC SARCOIDOSIS; CORTICOSTEROID;

AGED; ANTI-INFLAMMATORY AGENTS; ATRIOVENTRICULAR BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PREDNISOLONE; RETROSPECTIVE STUDIES; SARCOIDOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887137903     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.07.007     Document Type: Article

References (30)

1. Newman L.E., Rose C.S., Maier L.A. Sarcoidosis. N Engl J Med 1997, 336:1224-1234.
2. Kato Y., Morimoto S., Uemura A., Hiramitsu S., Ito T., Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 2003, 20:133-137.
3. Banba K., Kusano K.F., Nakamura K., Morita H., Ogawa A., Ohtsuka F., Ogo K.O., Nishii N., Watanabe A., Nagase S., Sakuragi S., Ohe T. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007, 4:1292-1299.
4. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord 2007; 27:89-102 [in Japanese].
5. Soejima K., Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009, 20:578-583.
6. Kasahara Y., Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 1981, 27:1922-1925.
7. Yazaki Y., Isobe M., Hiroe M., Morimoto S., Hiramitsu S., Nakano T., Izumi T., Sekiguchi M., Central Japan Heart Study Group Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisolone. Am J Cardiol 2001, 88:1006-1010.
8. Umetani K., Ishihara T., Yamamoto K., Sawanobori T., Kohno I., Ijiri H., Komori S., Tamura K. Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of gallium-67 and thallium-201 scintigraphy. Intern Med 2000, 39:245-248.
9. Sugishita K., Togashi Y., Aizawa A., Asakawa M., Usui S., Ito N., Yamaguchi T., Hada Y., Takahashi T. Postpartum complete atrioventricular block due to cardiac sarcoidosis. Steroid therapy without permanent pacemaker. Int Heart J 2008, 49:377-384.
10. Miyazaki S., Funabashi N., Nagai T., Uehara M., Kataoka A., Takaoka H., Ueda M., Komuro I. Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone. Int J Cardiol 2011, 150:e4-e10.
11. Takeda N., Yokoyama I., Hiroi Y., Sakata M., Harada T., Nakamura F., Murakawa Y., Nagai R. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 2002, 105:1144-1145.
12. Chiu C.Z., Nakatani S., Zhang G., Tachibana T., Ohmori F., Yamagishi M., Kitakaze M., Tomoike H., Miyatake K. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005, 95:143-146.
13. Yodogawa K., Seino Y., Ohara T., Takayama H., Katoh T., Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011, 16:140-147.
14. Valantine H., McKenna W.J., Nihoyannopoulos P., Mitchell A., Foale R.A., Davies M.J., Oakley C.M. Sarcoidosis: a pattern of clinical and morphological presentation. Br Heart J 1987, 57:256-263.
15. Sun B.J., Lee P.H., Choi H.O., Ahn J.M., Seo J.S., Kim D.H., Song J.M., Choi K.J., Kang D.H., Song J.K. Prevalence of echocardiographic features suggesting cardiac sarcoidosis in patients with pacemaker or implantable cardiac defibrillator. Korean Circ J 2011, 41:313-320.
16. Uemura A., Morimoto S., Kato Y., Hiramitsu S., Ohtsuki M., Kato S., Sugiura A., Miyagishima K., Iwase M., Hishida H. Relationship between basal thinning of the interventricular septum and atrioventricular block in patients with cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005, 22:63-65.
17. Okayama K., Kurata C., Tawarahara K., Wakabayashi Y., Chida K., Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995, 107:330-334.
18. Tadamura E., Yamamuro M., Kubo S., Kanao S., Saga T., Harada M., Ohba M., Hosokawa R., Kimura T., Kita T., Togashi K. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 2005, 185:110-115.
19. Baba Y., Kubo T., Kitaoka H., Okawa M., Yamanaka S., Kawada Y., Yamasaki N., Matsumura Y., Furuno T., Sugiura T., Doi Y.L. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. Int Heart J 2012, 53:287-292.
20. Shimada T., Shimada K., Sakane T., Ochiai K., Tsukihashi H., Fukui M., Inoue S., Katoh H., Murakami Y., Ishibashi Y., Maruyama R. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001, 110:520-527.
21. Patel M.R., Cawley P.J., Heitner J.F., Klem I., Parker M.A., Jaroudi W.A., Meine T.J., White J.B., Elliott M.D., Kim H.W., Judd R.M., Kim R.J. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009, 120:1969-1977.
22. Smedema J.P., Snoep G., van Kroonenburgh M.P., van Geuns R.J., Dassen W.R., Gorgels A.P., Crijns H.J. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005, 45:1683-1690.
23. Shafee M.A., Fukuda K., Wakayama Y., Nakano M., Kondo M., Hasebe Y., Kawana A., Shimokawa H. Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis. J Cardiol 2012, 60:448-453.
24. Uemura A., Morimoto S., Hiramitsu S., Kato Y., Ito T., Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999, 138:299-302.
25. Wilkoff B.L., Cook J.R., Epstein A.E., Greene H.L., Hallstrom A.P., Hsia H., Kawana A., Shimokawa H., Dual chamber and VVI Implantable Defibrillator Trial Investigators Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002, 288:3115-3123.
26. Tantengco M.V., Thomas R.L., Karpawich P.P. Left ventricular dysfunction after long-term right ventricular apical pacing in the young. J Am Coll Cardiol 2001, 37:2093-2100.
27. Okumura W., Iwasaki T., Toyama T., Iso T., Arai M., Oriuchi N., Endo K., Yokoyama T., Suzuki T., Kurabayashi M. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nuc Med 2004, 45:1989-1998.
28. Youssef G., Leung E., Mylonas I., Nery P., Williams K., Wisenberg G., Gulenchyn K.Y., Dekemp R.A., Dasilva J., Birnie D., Wells G.A., Beanlands R.S. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012, 53:241-248.
29. Akashi H., Kato T.S., Takayama H., Naka Y., Farr M., Mancini D., Schulze P.C. Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation-single-center retrospective analysis. J Cardiol 2012, 60:407-410.
30. Yodogawa K., Seino Y., Ohara T., Takayama H., Kobayashi Y., Katoh T., Takano T. Non-invasive detection of latent cardiac conduction abnormalities in patients with pulmonary sarcoidosis. Circ J 2007, 71:540-545.